GSK · 6 days ago
Summer Intern/Sales Operations & Analytics
GSK is a global biopharma company focused on uniting science, technology, and talent to improve health outcomes. The Sales Operations and Analytics intern will support sales operations by addressing field queries and analyzing datasets to provide insights and trends to the sales teams.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Maintaining first line responses to field queries around the analytic tools the field uses
Working across several different teams to identify resolution and/or escalation paths
Reviewing weekly datasets and identifying national and subnational market insights and trends to share with Market Development Directors
Qualification
Required
Pursuing a degree in Sales, Business Analytics, General business, and Analytics degrees are most relevant for this position
Must be able to work full-time (35-40 hours/week) throughout the duration of the 12 week internship (May/June ~ August 2026)
Must have an active student status and/or within 12 months post-graduation from a BS or MS degree program. Post-doctoral candidates are not eligible
Excellent communications skills—position will communicate across several business areas and levels, and must be comfortable with reducing complexity of technical answers to straight-forward language
Analytical abilities – Strong Excel skills and familiarity with utilizing tools (PowerBI) and/or languages (Python/SQL) to quickly parse large datasets to identify insights, issues, or trends
Focus on problem solving – Position will face a variety of challenges that will require unique solutions
Must successfully pass a drug screen and background check prior to assignment target start date
Completion of the immersive GSK Digital Assessment is required to proceed in the application process
Benefits
Relocation stipend
Competitive hourly pay rate and benefits
Overtime pay
Company
GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
Funding
Current Stage
Public CompanyTotal Funding
$25.51MKey Investors
CARB-X
2021-03-02Grant· $18M
2020-09-23Grant· $7.51M
1978-01-13IPO
Recent News
South China Morning Post
2026-01-08
2026-01-07
Company data provided by crunchbase